Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
DIH Holdings US, Inc. Class A Common Stock (DHAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: DHAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -16.25% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.88M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.03 | 52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.79% | Operating Margin (TTM) -17.49% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26684334 | Price to Sales(TTM) 0.17 |
Enterprise Value 26684334 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 47336300 | Shares Floating 15773934 |
Shares Outstanding 47336300 | Shares Floating 15773934 | ||
Percent Insiders 50.42 | Percent Institutions 12.13 |
Upturn AI SWOT
DIH Holdings US, Inc. Class A Common Stock
Company Overview
History and Background
DIH Holdings US, Inc. Class A Common Stock, focuses on advanced rehabilitation technology. Founded to address gaps in rehabilitation care, DIH has grown through organic development and acquisitions of rehabilitation technology companies.
Core Business Areas
- Rehabilitation Robotics: Development and sale of robotic devices for rehabilitation of upper and lower extremities.
- VR-Based Rehabilitation: Virtual reality systems and solutions for gamified rehabilitation therapy.
- Clinical Assessment Tools: Tools and technologies for assessing patient progress during rehabilitation.
- Tele-Rehabilitation Platform: Remote rehabilitation platform used to remotely connect patients with professionals.
Leadership and Structure
DIH Holdings US, Inc. has a leadership team with experience in medical technology and rehabilitation. The organizational structure includes departments for R&D, sales, marketing, and operations.
Top Products and Market Share
Key Offerings
- Hand Tutor: Robotic device for hand and wrist rehabilitation. Market share within robotic hand rehabilitation is estimated to be 15%. Competitors include Hocoma and Kinova.
- Diego: Robotic device for upper extremity rehabilitation. Competitors are Hocoma, Tyromotion, and Motorika.
- Motek CAREN: Advanced motion capture system for rehabilitation analysis and training. Competitors are Qualisys and Vicon. Market Share estimated at 10%.
Market Dynamics
Industry Overview
The rehabilitation technology market is growing due to an aging population, increasing incidence of stroke and other neurological disorders, and technological advancements.
Positioning
DIH Holdings US, Inc. is positioned as a provider of comprehensive rehabilitation solutions, integrating robotics, VR, and clinical assessment tools. Its competitive advantage lies in its portfolio of innovative technologies.
Total Addressable Market (TAM)
The global rehabilitation robotics market is projected to reach $2.6 billion by 2028. DIH Holdings US, Inc. is positioned to capture a portion of this TAM through its diverse product line.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Innovative technology
- Strong R&D capabilities
- Global presence
Weaknesses
- Relatively smaller market share compared to some competitors
- Dependency on healthcare reimbursement policies
- Brand recognition may be lower than established competitors
Opportunities
- Expanding into emerging markets
- Developing new applications for existing technologies
- Forming strategic partnerships with healthcare providers
- Increased adoption of telehealth and remote rehabilitation
Threats
- Intense competition
- Changing healthcare regulations
- Technological obsolescence
- Economic downturns impacting healthcare spending
Competitors and Market Share
Key Competitors
- Hocoma (Switzerland)
- Tyromotion (Austria)
- Motorika (Israel)
- Ekso Bionics (EKSO)
- ReWalk Robotics (RWLK)
Competitive Landscape
DIH Holdings US, Inc. competes with larger, more established companies in the rehabilitation technology market. Its competitive advantage lies in its diverse product portfolio and focus on innovation.
Major Acquisitions
Motek Medical
- Year: 2017
- Acquisition Price (USD millions): 50
- Strategic Rationale: Acquisition of Motek Medical expanded DIH's capabilities in advanced motion capture systems for rehabilitation.
Hocoma
- Year: 2019
- Acquisition Price (USD millions): 131
- Strategic Rationale: Acquisition of Hocoma, the global leader in robotic rehabilitation, significantly broadened DIH's product portfolio and market presence.
Growth Trajectory and Initiatives
Historical Growth: DIH Holdings US, Inc. has demonstrated growth through acquisitions and organic expansion of its product portfolio.
Future Projections: Analyst estimates project continued growth in revenue and profitability, driven by demand for rehabilitation technology.
Recent Initiatives: Recent initiatives include expanding its telehealth platform and developing new VR-based rehabilitation programs.
Summary
DIH Holdings US, Inc. is a significant player in the rehabilitation technology market, boasting a diverse product range and innovative technologies. Its growth has been fueled by strategic acquisitions and organic development. Facing competition from established players, its success hinges on continued innovation, market expansion, and navigating healthcare regulations.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Analyst Estimates
- Press Releases
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DIH Holdings US, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Norwell, MA, United States | ||
IPO Launch date 2022-03-21 | Founder, Chairman & CEO Mr. Jason Chen | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.dih.com |
Full time employees - | Website https://www.dih.com | ||
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.